miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

A. Holleman; I. Chung; R.R. Olsen; B. Kwak; A. Mizokami; N. Saijo; A. Parissenti; Z. Duan; E.E. Voest; B.R. Zetter

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

A. Holleman
, I. Chung
, R.R. Olsen
, B. Kwak
, A. Mizokami
, N. Saijo
, A. Parissenti
, Z. Duan
, E.E. Voest
, B.R. Zetter

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	4386-4398
Number of pages	13
Journal	Oncogene
Volume	30
Issue number	43
Publication status	Published - 2011

Cite this

@article{fd43097c1b4144129f490528a2a8bca4,

title = "miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.",

author = "A. Holleman and I. Chung and R.R. Olsen and B. Kwak and A. Mizokami and N. Saijo and A. Parissenti and Z. Duan and E.E. Voest and B.R. Zetter",

year = "2011",

language = "English",

volume = "30",

pages = "4386--4398",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "43",

}

TY - JOUR

T1 - miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

AU - Holleman, A.

AU - Chung, I.

AU - Olsen, R.R.

AU - Kwak, B.

AU - Mizokami, A.

AU - Saijo, N.

AU - Parissenti, A.

AU - Duan, Z.

AU - Voest, E.E.

AU - Zetter, B.R.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0950-9232

VL - 30

SP - 4386

EP - 4398

JO - Oncogene

JF - Oncogene

IS - 43

ER -